The share

Inify Laboratories AB is listed on Euronext Growth Oslo since June 20th, 2022. All shares have equal rights and are freely transferable. Please follow the development of the Inify Laboratories share on Euronext Growth and view stock exchange releases at NewsWeb.

Share information

Ticker code
Number of shares
Trading currency
LEI code

Health care


Inify Laboratories AB is listed on Euronext Growth Oslo under the ticker INIFY.
The list of total shares and the 20 largest shareholders is updated monthly, usually at month end. The last update was made on December 1st 2023. The company has a total of 45,236,750 outstanding shares.

20 largest shareholders

Number of shares heldOwnership (%)Shareholder
27 181 38660,09%Gallivant S.á.r.l.
4 691 41210,37%Tauri AS
1 964 7684,34%Günther-Hanssen, Sven
1 876 4094,15%Danske Bank A/S
1 372 2433,03%MP Pensjon PK
1 000 1512,21%Bras Kapital AS
986 9502,18%Monsun AS
707 5861,56%Stavland, Bernt
648 1671,43%Stavland, Anders
425 8000,94%Stavland, Per
407 6280,90%Avanza Bank AB
281 7170,62%Sveen, Kristian
265 9760,59%Olsen, Lars Ejnar
184 4080,41%Skandinaviska Enskilda Banken AB
172 6970,38%Danske Bank A/S
166 2310,37%Skjelbred, Rune
141 0390,31%B Stavland Holding AS
116 6190,26%Swedbank AB
95 2250,21%Mæland, Edmund
90 2340,20%Svenska Handelsbanken AB
2 460 1045,44%Others
45 236 750100,00%Total

Primary Insider Transactions

Information about primary insider transactions can be found under Investor news.

Dividend policy

The board of Inify Laboratories AB has not adopted a dividend policy since the Company considers itself to be in a growth phase, and therefore does not foresee that it will pay dividends in the near future. In deciding whether to propose a dividend and in determining the dividend amount, the Board of Directors will take into account legal restrictions as well as capital expenditure plans, financing requirements and maintaining the appropriate strategic flexibility.